NCT05025527

Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Shanghai East Hospital · Academic / Other
• Sex: Male
• Age: 50 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This is a single centre non-inferiority randomized controlled trial in comparison of the bpMRI between the traditional pathway in prostate cancer screening

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	biparametric MRI (bpMRI)	Men go for the bpMRI for PCa (prostate cancer) screening, those who had a suspicious result will go for the next confirmation test
DIAGNOSTIC_TEST	Prostate cancer antigen (PSA)	Men go for the PSA test for PCa screening, those who had a suspicious result will go for the next confirmation test

Timeline

• Start date: 2022-12-01
• Primary completion: 2024-12-01
• Completion: 2024-12-01
• First posted: 2021-08-27
• Last updated: 2022-10-28

Locations

1 site across 1 country: China